Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the most effective route to administer steroids to patients with chronic sinusitis, specifically a type of chronic sinusitis not associated with nasal polyps (CRSsNP). The investigators would like to better understand whether orally administered steroids results in superior results when compared with nasally sprayed steroids. The investigators propose to test the hypothesis that for patients with radiographically proven CRSsNP, routine medical therapy consisting of a short course of systemic corticosteroids is superior to topical corticosteroids for relieving inflammation and the symptoms of CRS.


Clinical Trial Description

Chronic sinus infections (chronic sinusitis or CRS) are common conditions that affect millions of Americans. While this is a common disorder, medical treatments for this condition vary a lot and little is known how and why different treatments work in some individuals and not in others. Some physicians commonly utilize a course of oral steroid therapy similar to treatment of inflammatory conditions including asthma and arthritis. Other physicians feel that oral steroids are not more effective than nasal steroid sprays in reducing inflammation and prefer prescribing nasal steroids. There is no conclusive data as to whether oral or sprayed nasal steroids are more effective in providing long-term benefit to patients. Nasal steroids are FDA approved to treat some types of chronic sinusitis but oral steroids are FDA approved medications that are used to treat inflammatory conditions but is not specifically indicated for chronic sinusitis and thus should be regarded as investigational drug. The purpose of this research study is to better understand whether orally administered steroids results in superior results when compared with nasally sprayed steroids. The investigators will compare patients with chronic sinusitis who are first treated with antibiotics and oral steroids, and compare them to chronic sinusitis patients who receive antibiotics and nasally sprayed steroid therapy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01676415
Study type Interventional
Source Northwestern University
Contact
Status Terminated
Phase Phase 4
Start date August 2012
Completion date August 2016

See also
  Status Clinical Trial Phase
Recruiting NCT06069310 - Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
Recruiting NCT06013241 - A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Phase 2
Active, not recruiting NCT05553951 - Adherence in Global Airways N/A
Active, not recruiting NCT06118554 - 3D Printing to Improve Nasal Irrigation Outcome N/A
Recruiting NCT06398873 - Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP
Withdrawn NCT04158596 - Safety and Efficacy of SDX-3101 for the Treatment of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) N/A
Recruiting NCT05642806 - Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment Phase 4
Completed NCT04678856 - Dupilumab in CRSsNP Phase 2
Recruiting NCT05843019 - Adherence in Global Airways - Steroid Intake and Effects on Chronic Rhinosinosinutis